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Abstract
Dietary folates have a key role to play in health as deficiencies in the intake of
these B vitamins have been implicated in a wide variety of clinical conditions.
The reason for this is folates function as single carbon donors in the synthesis of
methionine and nucleotides. Moreover, folates have a vital role to play in the
epigenetics of mammalian cells by supplying methyl groups for DNA methylation
reactions. Intriguingly, a growing body of experimental evidence suggests DNA
methylation status could be a central modulator of the ageing process. This has
important  health  implications  because  the  methylation  status  of  the  human
genome could be used to infer age-related disease risk. Thus, it is imperative we
further our understanding of the processes which underpin DNA methylation and
how these intersect with folate metabolism and ageing.  The biochemical  and
molecular mechanisms which underpin these processes are complex. However,
computational modelling offers an ideal framework for handling this complexity.
A number of computational models have been assembled over the years, but to
date no model has represented the full  scope of the interaction between the
folate cycle and the reactions which govern the DNA methylation cycle. In this
review we will  discuss  several  of  the models  which  have  been developed to
represent these systems. In addition we will present a rationale for developing a
combined model of folate metabolism and the DNA methylation cycle. 
Keywords:  folate metabolism, computational model, DNA methylation, ageing, 
stochastic model
Introduction 
The term ‘folate’ (vitamin B9) is used to denote a group of compounds which
possess the same vitamin activity and includes natural folates as well  as the
pharmacological  compounds  folic  acid  and  folinic  acid  [1].  The  dietary
importance of folate cannot be overstated. This is emphasized by the wide range
of  clinical  disorders  which  correlate  with  low  folate  status  [2-4].  In  addition,
polymorphisms  in  genes  coding  for  folate  dependent  enzymes  [5,  6]  are
associated with several  cancers (cervical,  bronchial,  colon and breast)  [7-10],
Alzheimer’s  disease  [11],  Down  syndrome  [12],  unexplained  recurrent  early
pregnancy loss and pre-eclampsia [13].These associations are unsurprising when
one  considers  that  folates  are  involved  in  a  ubiquitous  array  of  cellular
processes. For instance, folates are involved in the synthesis of nucleotides from
purine  precursors,  participate  indirectly  in  the  synthesis  of  transfer  RNA and
function  as  single  carbon  donors  during  the  re-methylation  of  homocysteine
(Hcy) to methionine [14] (Figure 1). Folate-derived one-carbon units also play a
central role in DNA methylation [15, 16]. This epigenetic process involves methyl
groups  covalently  bonding  to  CpG  dinucleotides  to  establish  tissue  specific
methylation patterns. A CpG dinucleotide consists of a deoxycytidine followed by
a deoxyguanidine, with the “p” indicating the phosphate group between these
nucleotides. Covalent bonding of methyl groups occurs at the carbon-5 position
of a deoxycytidines to create a methylated CpG dyad [11, 12]. Dynamic changes
to  methylation  patterns  are  an  important  gestational  phenomenon,  which
regulate gene expression during embryonic development [17]. However, during
adult  life  alterations  to  DNA  methylation  patterns  can  have  significant
implications for the onset of disease [18, 19]. Specifically, advancing age is often
accompanied by global hypomethylation [20-23] in conjunction with site specific
hypermethylation  at  the  promoter  region  of  a  variety  of  genes  [24-27].
Hypermethylation,  involves  CpG  islands  (~500-2000  base  pairs)  within  the
promoter  becoming  excessively  methylated  [28,  29],  and  often  occurs  with
concomitant transcriptional silencing [30, 31]. Gene promoter hypermethylation
is a feature of certain diseases, the most notable being cancer [25]. For instance,
Wang  et al. (2016) [32] recently found that  DNA methylation changes during
ageing were closely correlated to the occurrence of cancer. In addition to cancer
aberrant DNA methylation has an emerging role to play in many age related
diseases including, cardiovascular disease (CVD) [33], Alzheimer’s disease [34]
and osteoporosis/osteoarthritis [35]. Such findings consolidate the growing view
that DNA methylation status and health-span are inexorably entwined. Moreover
it has also been revealed that investigating changes to the methylation profile of
the genome could help develop our understanding of ageing.  This  assertion is
supported by the recent bioinformatics work of Horvath (2013) [36] who utilized
publicly  available  methylation  data  sets  to  identify  an  “epigenetic  clock  “
underpinned  by  methylation  changes  in  353  CpGs.  Intriguingly,  Horvarth
postulates that “DNA methylation age” measures the cumulative effect of  an
epigenetic maintenance system. This finding indicates that a deeper mechanistic
understanding of DNA methylation preservation could be pivotal to improving our
overall understanding of ageing and health-span.  
To extend our understanding of DNA methylation and its bidirectional relationship
with ageing it  is  imperative we consider how subtle alterations to folate one
carbon metabolism (FOCM) impact the regulatory  processes which govern DNA
methylation. Specifically, it is necessary to explore how such perturbations affect
gene promoters which are susceptible to hypermethylation. In addition, it is vital
we consider how other factors associated with ageing impact this relationship.
However,  this  is  not  a  straightforward  task  as  both  FOCM  and  the  DNA
methylation  cycle  are  complex  processes  which  are  underpinned  by  a  large
number  of  biochemical  and  molecular  reactions  (Figure  1).  Many  of  these
reactions are non-linear in nature and are influenced by a variety of  other B
vitamins/nutrients and enzymatic cofactors [37]. Ageing adds a further degree of
complexity  by  altering  the  dynamics  of  the  reactions.  For  example,  age-
dependent  decreases  in  the  expression  levels/activity  of  human  methionine
synthase  (MS) and  methylenetetrahydrofolate  reductase  (MTHFR)  have  been
observed [38, 39]. Both enzymes are recognised as key regulators of FOCM and
expression/activity  changes potentially  affect  their  reaction kinetics.  Similarly,
the activity of human DNA methyltransferase 1 (Dnmt 1), a key enzyme involved
in the addition of methyl groups to cytosine residues, has also been observed to
decrease with age [40]. Moreover, ageing also affects the availability of cofactors
such as vitamin B12 [41], which is central to FOCM, while oxidative stress, which
is generally regarded as a key contributor to ageing, has been observed to effect
both DNA methylation and FOCM [42, 43]. Furthermore, it is not uncommon that
older people have diminished folate status as a result of a low dietary intake of
the  vitamin  [44].  Thus,  it  is  necessary  to  consider  an  array  of  factors  when
investigating  the  maintenance  of  DNA  methylation.  Fortunately,  there  is  a
growing appreciation that complex biological process can be studied in a holistic
manner by adopting a systems biology approach [45]. Computational modelling
resides  at  the  centre  of  this  paradigm  shift  as  it  provides  a  framework  for
representing and exploring the dynamics of  complex systems [46-50].  In  this
review we discuss the role computational modelling has played in developing our
understanding of FOCM and DNA methylation. In addition we propose coupling
FOCM and the DNA methylation cycle into one computational model, which could
be used to further explore the dynamics of their relationship. 
Folate metabolism and the DNA methylation Cycle
FOCM is fundamentally important to DNA methylation. Various folates are the
cofactors for the  de novo synthesis of methyl groups from more oxidized one
carbon units and 2) the methyl groups on 5-methyltetrahydrofolate are used to
re-methylate  hcy  to  methionine  and  to  regenerate  tetrahydrofolate,  the
metabolically  active  form  of  folate.  Methionine  is  a  precursor  of  S-
adenosylmethionine (SAM), which has a predominant role to play in the majority
of biochemical methyl donation events, including that of DNA methylation. Post
replication, Dnmt1 uses SAM as a substrate to transfers methyl groups to the
DNA molecule [51] this produces S-adenosylhomocysteine (SAH). SAH is then
converted to Hcy permitting the continuation of the methylation cycle [52, 53]
(Figure 1). In conjunction with Dnmt1 DNA methylation patterns are dynamically
regulated by several other enzymes (Figure 1). As, Dnmt1 preferentially acts on
hemimethylated  DNA and  is  potentially  unable  to  methylate  neo-synthesized
DNA strands, this enzyme is generally regarded as solely a maintenance enzyme
[54].Thus,  other  enzymes  are  needed  to  perform  de  novo DNA methylation.
Dnmt3a and Dnmt3b are widely regarded as the main enzymes responsible for
this role [55, 56]. These methylation reactions are offset by active and passive
demethylation.  Passive  demethylation  occurs  during  replication,  while  active
methylation  can  involve  ten  eleven  translocation  (TET) dioxygenases,  which
oxidize  the  methyl  groups  of  cytosine  [57].  TET are  thought  to  function  by
oxidizing the methyl groups of cytosine. This process eventually culminates with
the reintroduction of unmethylated cytosine in the DNA molecule [57]. Thus, it
would appear that the steady state levels of both site specific and global DNA
methylation patterns are maintained by an antagonistic balancing act between
those  activities  responsible  for  maintenance/de  novo  methylation  and  those
reactions  responsible  for  passive/active  demethylation.  Moreover,  methylation
fidelity studies suggest these processes are subject to inherent stochasticity. For
example, Landan et al. (2012) [58] tracked the in vitro evolution of immortalized
fibroblasts for >300 generations and found that changes in population-averaged
methylation occur through a stochastic process. In addition, Shipony et al. (2014)
[59] suggest  the persistence  nature  of  the somatic  methylome is  one factor
which makes it increasingly vulnerable to noise with time. This is intriguing from
the perspective of ageing  as it would appear that in young somatic cells, site
specific methylation density is characterised by low level noise, which maintains
average methylation density. Therefore, the persistent nature of the methylome
and  increased  stochasticity  with  time  could  contribute  to  the  formation  of
aberrant DNA methylation patterns which are a hallmark of the ageing process in
humans. 
Computational Models of Folate Metabolism 
The models described in the next two sections are summarised in Table 1 and 2
respectively. Models  of  FOCM  have  traditionally  adopted  a  continuous
deterministic approach, with the dynamics of the system being represented by
ordinary  differential  equations  (ODEs),  which  are  underpinned  by  kinetic
reactions  [60].  In the main reaction velocities are assumed to depend on the
concentrations of the reaction substrates (the law of mass action [61]). Rate laws
for more complex reactions laws are in general described by Michaelis–Menten
kinetics  [62]  for  one,  two,  or three  substrates  assuming  a  random-order
mechanism.  The following  mathematical  expressions  taken  from  the  recent
model  by  Salcedo-Sora  and  Mc  Auley  (2016)  [63] encapsulate  the  different
Michaelis–Menten  based  functional  forms  as  used  for  one ,  two,  and  three
substrates  in  these  types  of  kinetic  models,  where  V  is  the  velocity  of  the
reaction, Vmax, is the theoretical maximum velocity of the reaction, S1 to S3 are
substrates and km1 to km3 are the substrate concentrations at which the reaction
is half maximum velocity. 
The  first  mathematical  model  to  adopt  this  kinetic  approach  to  represent
intracellular folate metabolism was developed in the 1970s and had a strong
pharmacological theme [64]. It was used to simulate the actions of methotrexate
on DNA synthesis. The next significant computational model of the folate cycle,
was developed by  Nijhout  et al. (2004) [65]. This model is underpinned by the
enzyme  kinetic  data  that  characterises  the  reactions  in  Figure  1,  and  was
assembled using the type of mathematical equations outlined above. As well as
being  the  first  detailed  mathematical  description  of  the  folate  cycle,  model
simulations were able to quantitatively reproduce the intracellular levels of the
various  folate  metabolites  and  the  model  was  able  to  predict  the  effect  of
vitamin B12 deficiency. Building on this work,  Reed et al. (2006) [66] used this
model combined with models of methionine metabolism [67, 68] to investigate
genetic polymorphisms in the folate pathway. Polymorphisms in MTHFR predicted
a reduction in MTHFR activity reduces concentrations of SAM and 5-MTHR, and
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DNA  methylation,  while  slightly  increasing  SAH  and  hcy  concentrations  and
thymidine  or  purine  synthesis.  Decreased  folate  together  with  a  simulated
vitamin B12 deficiency resulted in decreased DNA methylation and purine and
thymidine synthesis. This model was also used as a template to study the effect
of  intracellular  folate  deficiency  and  excess.  The  model  suggested  that  the
enzyme  thymidylate  synthesis  is  very  sensitive  to  changes  in  epithelial
intracellular  folate  and  increased  significantly  under  conditions  of  high
intracellular folate [69]. This framework was further extended by Duncan et al.
(2013) [70] to hepatic and plasma folate turnover. It was applied to a population
of  virtual  individuals  and  showed  that  tissue  and  plasma  folate  is  highly
correlated,  but  liver  and  plasma  folate  much  less  so.  Moreover,  this  model
showed  that  oxidative  stress  increases  the  plasma  S-adenosylmethionine/S-
SAM/SAH ratio. The most recent ODE model of folate metabolism was developed
by Salcedo-Sora and Mc Auley (2016) [63]. Our model is the first computational
model of microbial folate biosynthesis and utilisation. Using the model we were
able to identify specific targets within folate metabolism which synergise with
current antifolates. In addition the results from our model support experimental
findings  which  suggest  the  folinic  acid  substrate  cycle  is  an  important
biochemical mechanism deployed during active cell growth. A key finding which
emphasizes  the  utility  of  computational  models  for  shedding  light  on  this
complex system. 
Computational Models of the DNA Methylation Cycle
A  variety  of  approaches  have  been  used  to  model  various  aspects  of  DNA
methylation  [71-79].  Our  focus  is  the  precise  representation  of  the  DNA
methylation cycle.  To this end the DNA methylation cycle has been modelled
explicitly by McGovern et al. (2012) [80]. The model centred on the activity of
DNMTs  and  partial  differential  equations  was used  to  represent  methylation
reactions. It was used as a predictive tool for haematological malignancies. The
model  was  able  to  predict  the  relative  abundances  of  unmethylated,
hemimethylated,  fully  methylated,  and  hydroxymethylated  CpG  dyads  in  the
DNA of cells with fully functional methylation and TET enzymes. In addition to
this deterministic framework stochastic models of the methylation cycle have
also been used to study the methylation cycle.  The goal  has been to derive
models  which  account  for  the  noise  associated  with  maintaining  DNA
methylation  levels.  For  example,  a  reduced  probabilistic  mathematical
representation of methylation dynamics (known as the standard/classical model)
has been proposed by Pfeifer et al. (1990) [81], and further utilised by Riggs and
Xiong (2004) [82]. This model is presented in equations 4-7. 
To briefly explain ODEs 4 and 5, and equations 6 and 7, M is a CpG site, U is its
unmethylated  state,  Ed is  the  efficiency  of  de  novo methylation,  Em is  the
efficiency of maintenance methylation, M is the number of methylated sites, M∧
is  the  fraction  of  methylation,  while  equation  7  represents  the  steady  state
solution to ODEs 4 and 5 when dM∧/dt=0. This model is underpinned by the idea
that  site specific methylation levels  are  underscored by a stochastic  process,
where  de novo and  maintenance  methylation  activity  are  central.  Recently
Jeltsch and Jurkowska (2014) [83] provided an intriguing theoretical extension to
this  concept.  Jeltsch  and  Jurkowska  propose  a  stochastic  model  which  also
includes the rate of cell division together with passive and active demethylation
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(equation 8). 
i
m , is the change in the fraction of methylation at any CpG site (i).
This  is  determined  by  the  difference  between  the  rate  of  de  novo DNA
methylation  (
i
metr )  and  rates  of  loss  of  methylation  by  replication  and  active
demethylation  (
i
demethr )  at  this  site.  D,  is  the  rate  of  cell  division,  
i
mainf  is  the
efficiency of maintenance methylation at site i.  
According  to  the  authors,  equation  8  has  the  significant  advantage  over  its
predecessor as it includes the possibility of proofreading/repair mechanisms due
to the incorporation of  negative feedback.  This level  of  regulation is  attained
because  an  increase  in  methylation  causes  a  reduction  in  the  first  term  of
equation 8 with a subsequent increase in the second term. Consequently the
methylation rate drops and demethylation increases, resulting in a stable steady-
state methylation level at each site. To our knowledge this theoretical framework
has yet to be applied to experimental data or simulated dynamically. A stochastic
mathematical  framework  also  inspired  Haerter  et  al.  (2014)  [84] to  create  a
computational  model  of  this  system.  Their  model  differs  from  the
classical/standard  model  as  it  included  dynamic  collaboration  between  CpGs.
More recently Olariu et al. (2016) [85] built on the work of Haerter et al. (2014)
to model the regulation of transcription and DNA methylation.
Rationale  for Computationally  Integrating  FOCM  and  the  DNA
Methylation Cycle
Computational models of FOCM are not fully integrated with the DNA methylation
cycle.  Rather,  as  outlined they have been restricted to the cycle  itself  or  its
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involvement  with  DNA  synthesis  and  have  tended  not  to  include  the  DNA
methylation cycle. Some have attempted to account for DNA methylation but no
model to our knowledge has explicitly integrated both systems in a meaningful
way. We propose computationally integrating FOCM and the methylation cycle.
Our biological rationale is unpinned by the knowledge that perturbations in the
folate  cycle  are  strongly  coupled  with  aberrant  DNA  methylation.  This  is
evidenced  by  the  association  between  low  folate  status,  global  DNA
hypomethylation  and  increased  cancer  risk  [86].  In  addition,  genetic
polymorphisms most notably in the MTHFR gene, which codes for  MTHFR, an
enzyme which catalyses the conversion of 5, 10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate (5-MTFHF) (Figure 1) is associated with gene promoter
hypermethylation [87]. Moreover, methionine synthase A2756G (MTR A2756G) is
a common polymorphism in the gene encoding  MS. This enzyme catalyses the
regeneration of methionine from hcy and disruptions to its enzymatic capabilities
also emphasise the close link between folate metabolism and disruptions to DNA
methylation.  For  instance,  Weiner  and  colleagues  (2014)  [87] found  that
individuals homozygous for this mutant allele showed higher leukocyte genomic
DNA methylation levels than individuals possessing the wild-type genotype (MTR
2756AA). It makes mechanistic sense that perturbations of this nature to FOCM
have  an  impact  on  DNA  methylation,  as  5-methyltetrahydrofolate,  is  a
cosubstrate  for  hcy  remethylation  to  methionine,  while  MS  modulates  the
dynamics of this reaction and perturbations to this enzyme result in a rise in
plasma hcy [88], which is associated with CVD [89]. Intriguingly, a rise in plasma
hcy has also been associated with gene promoter hypermethylation [90-93] and
global hypomethylation [94-96] of human DNA. 
In addition to perturbations due to genetic mutations it is important to recognise
that FOCM compartmentalisation could have implications for DNA methylation
status as compartmentalisation of  FOCM has a role  to  play in regulating the
distribution of one-carbon units within the cell.  The partitioning of one-carbon
units between nucleotide synthesis and hcy remethylation is the focal point of
this  process,  where  methylenetetrahydrofolate  (MTHF)  is  at  the  centre  of  a
metabolic competition [97, 98].  On the one hand MTHF is used as a cofactor
during  nucleotide  synthesis  to  facilitate  the  conversion  of  dUMP to  dTMP by
thymidylate synthase (TYMS). However, MTHF can also be reduced and is then
fully committed to the remethylation of hcy. The separation of FOCM into distinct
cellular compartments is the determining factor which regulates the competition
between  TYMS  and  MTHFR  for  MTHF  [99].  This  regulation  requires  the
trifunctional,  enzyme  methylenetetrahydrofolate  dehydrogenase  (MTHFD1),
whose activity depends on its cellular location [99]. The interdependence of this
enzymes activity to its location and its involvement in regulating the competition
between  MTHFR  and  TYMS  is  evident,  when  intracellular  folate  levels  are
deficient, as insufficient levels of folate cause an accumulation of MTHFD1 in the
nucleus, when compared to its cytosolic counterpart [100]. The nuclear build-up
of  MTHFD1  emphasises  FOCM  will  sacrifice  hcy  remethylation  in  favour  of
nucleotide synthesis and underscores the regulatory role compartmentalisation
plays in one-carbon metabolism.  Intriguingly  this  aspect  of  FOCM could  have
wider implications as recently it has been shown that changes to MTHFD1 can
affect the regulation of DNA methylation. Groth  et al. (2016) [101] identified a
mutant  (mthfd1-1)  in  Arabidopsis  thaliana, which  carried  a  mutation  in
cytoplasmic MTHFD1. This mutant suffered from accumulation of hcy and SAM,
coupled  with  extensive  genome-wide  hypomethylation.  Compartmental
regulation  of  FOCM is  also  highlighted  by  cyserine  hydroxymethyltransferase
(SHMT).  SHMT1  catalyses  the  conversion  of  tetrahydrofolate  (THF)  to  5,  10-
methylenetetrahydrofolate and also converts serine to glycine. It has been found
that cytosine serine hydroxymethyltransferase (cSHMT1) preferentially supplies
one-carbon units for thymidylate synthesis [98, 102]. Mechanistically, it is has
been found this preference is mediated by small ubiquitin-like modifier (SUMO)
modification. This alteration enables the  translocation of  SHMT to the nucleus
and  also  modifies  its  catalytic  capabilities  [103].  Sumoylation  could  also  be
crucial to both DNA methylation and demethylation as SUMO-1 modification of
DNMT1 had been shown to significantly enhance DNMT1 activity [104]. It is also
possible  sumoylation  is  capable  of  modulating  the  activity  of  Dnmt3a  and
Dnmt3b  [105].  This  level  of  crossover  between  FOCM and  DNA  methylation
consolidates the view that  disruptions to FOCM impact  the dynamics of  DNA
methylation/demethylation events. However, the full extent of this relationship
remains  to  be  elucidated,  hence  the  growing  need  for  an  integrated
computational model to explore the complex interactions of these systems. 
Theoretical Frameworks and Obstacles to Creating a Combined Model 
To develop a combined model several theoretical approaches could be adopted.
FOCM could be retained as a set of kinetic based ODEs, as is the case in the
majority of models of this nature. It would then be straightforward to add the
methylation cycle as ODEs also and to define the combined system as a coupled
set of ODEs. Despite the obvious computational advantages of this simplification,
these benefits are offset by several factors. Firstly, to assemble this deterministic
model the ODEs need to be informed by kinetic data, which accounts for the
behaviour  of  the  methylation  enzymes.  This  is  not  a  straightforward  task  as
parameter uncertainty is a significant issue in the field of computational systems
biology. As outlined, kinetic based models of folate metabolism tend to have rate
laws where the velocity of a reaction assumes mass action kinetics or is based on
an  enzyme kinetic  law (e.g.  Michaelis–Menten  kinetics). Unfortunately  kinetic
parameters can vary significantly depending on the circumstances in which their
kinetics were quantified and the biological source, with the possibility of model
parameters varying by several orders of magnitude depending on the particular
source [106]. Therefore, it is extremely unlikely that a mathematical model can
be assembled from one biological source. This is highlighted by our recent model
of  microbial  folate  metabolism,  where  the  parameters  were  derived  from  a
number of sources [63].  It  is also a feature of the mammalian computational
models which have previously relied on data from rat, mice and human studies
[65]. Despite such pitfalls, there is no alternative to this approach of determining
model parameters. To this end, a number of databases now exist which archive
kinetic data for the purpose of assembling computational models [107, 108]. We
used these databases to identify a series of indicative kinetic parameters for the
model outlined diagrammatically in Figure 1 and are summarised in Table 3. The
identification  of  these  parameters  serve  to  emphasize  that  it  is  possible  to
assemble  a  combined  kinetic  model  of  folate  metabolism  and  the  DNA
methylation cycle based on human data, however the data is limited. Moreover,
we were able to identify kinetic parameters for Dnmt1 and Dnmt3A [109, 110],
however kinetic information for the TET demethylation enzymes could not be
identified. 
Although  as  outlined  above  it  is  clearly  possible  to  assemble  a  combined
deterministic  kinetic  model,  given  experimental  evidence  indicates  DNA
methylation  events  are  underscored  by  stochasticity  a  kinetic  based
deterministic approach is not the correct way to model this aspect of the system.
A more accurate way is to incorporate noise into the model. The standard way of
representing noise within biological cells is to describe it mathematically by a
master  equation  or  to  simulate  molecule  fluctuations  by  using  a  stochastic
simulation  algorithm  (SSA),  such  as  the  Gillespie  algorithm  or  one  of  its
derivatives [111, 112]. Routinely embedded within the idea of intracellular noise
is the concept of intrinsic versus extrinsic noise, as developed experimentally by
Elowitz and colleagues (2002) [113]. Within this context intrinsic noise refers to
the variability inherent to the system under consideration, while fluctuations in
those factors classified as external to the system of interest are responsible for
extrinsic  noise  (Figure  2).  Specifically,  this  mathematical  approach  has  been
ubiquitously applied to the study of  cell  to cell  variability in  gene expression
levels within isogenic cell populations [114-117]. 
Applying the above logic to our indicative model it can be argued the reactions of
the  methylation  cycle  are  responsible  for  generating  intrinsic  noise  e.g.  the
inherent statistical mechanical fluctuations in the binding and diffusion dynamics
of  the  molecules  involved  in  maintaining  methylation  levels  within  a  CpG
island/gene body. Conversely, DNA methylation/the epigenetic state of the cell is
considered  to  be  a  component  of  extrinsic  noise  when  variations  in  gene
expression are modelled in this way. We suggest extrinsic noise in our integrated
model arises due to biochemical  fluctuations originating from the folate cycle
and  other  cell  parameters  particularly  those  related  to  ageing  (Figure  2).
Including  biochemical  noise  arising  from  FOCM  is  crucial  especially  if  one
considers that site specific (e.g. gene promoter) DNA methylation events interact
with  FOCM  within  a  microscopic  rather  than  macroscopic  environment.  This
microenvironment is characterised by low molecular populations, which react at
discrete  time-points,  via  random collisions  between individual  molecules.  The
advantage of this framework is its simplicity as a complex biological network is
reduced to a much simpler abstraction. A drawback of this approach is that it
reduces  the  methylation  cycle  and  FOCM  to  two  variables  within  a
phenomenological  model,  which lumps all  sources of  extrinsic  noise together.
Moreover, as we are concerned with the complexities of the reactions of folate
metabolism and how changes to these impact  DNA methylation events,  it  is
challenging to separate this source of noise from other extrinsic events e.g. the
impact of the cell cycle. A further challenge associated with this proposal is that
in order to characterise the intrinsic noise for a given gene promoter it would be
necessary  to  experimentally  characterise  promoter  specific  cell  to  cell
methylation variability in young disease free cells and how this relates to protein
expression levels. For instance, microscopy or flow cytometry are routinely used
to  quantify  protein  expression  variability  in  reporter  genes  embedded  in
homogenous cell populations [118, 119]. Protein count distributions then provide
an overview of cell to cell fluctuations in gene expression. The stochastic profile
can  then  be  characterised  as  the  squared  coefficient  of  variation  of  the
fluorescence levels [120], the coefficient of variation [113] or the Fano Factor
[121]. Therefore, it would be necessary to develop experimental methods which
are  capable  of  determining the  exact  nature of  the  stochasticity  of  the  DNA
methylation process. However, given that DNA methylation levels are quantified
in a totally different manner to protein fluctuations it is could be challenging to
define/characterise its stochastic signature in a precise way experimentally. Next
generation sequencing techniques could help to alleviate this problem. These
techniques enable the determination of the methylation status at each cytosine
for a specific segment of the genome. An eloquent example of this approach is
the work of Hansen et al. (2011) [122], who showed stochastic methylation of
cancer-specific DNA-methylated regions. This was able to distinguish cancer from
normal tissue. More recently Cheow et al. (2016) [123] developed a method to
genotype individual cells while concurrently probing gene expression and DNA
methylation  levels  at  multiple  loci.  Such  methods  could  help  identify  an
individual stochastic signature for a particular gene promoter/gene body, which
would help inform the mathematics underpinning future computational models.
An alternative to the reduced stochastic model approach would be to explicitly
represent  each  deterministic  kinetic  reaction  within  FOCM  and  the  DNA
methylation  cycle  as  stochastic  propensity  functions  and  to  simulate  the
integrated  model  with  a  SSA  [99],  as  has  been  done  with  other  complex
biochemical systems [124]. In Figure 2 part b we have created a list of reactions
which could be represented as propensity functions, where C1-  C7 are indicative
of stochastic rate constants. This is not unrealistic as mathematical approaches
have been developed previously  for  converting deterministic  systems biology
models into stochastic models [125-127]. However, regardless of the approach it
is  our  opinion  that  future  computational  models  should  combine  these  two
systems together. Moreover, it is imperative that any combined model accounts
for the biochemical and molecular variability which is inherent to both systems.
This will improve our overall understanding of how those gene promoters which
appear  to  be  susceptible  to  hypermethylation  interact  with  both  folate
metabolism and the ageing process. 
Conclusions
Folate metabolism and the DNA methylation cycle are inexorably entwined as the
folate  cycle  provides  the  methyl  groups  used  in  DNA  methylation  reactions.
Experimental evidence suggests the dynamics of the folate cycle and the DNA
methylation  cycle  are  subject  to  inherent  stochasticity.  Investigating  this
behaviour  is  challenging,  however  computational  modelling  offers  and  ideal
framework for  exploring  the  interactions  between these  two systems.  In  this
review  we  proposed  building  a  computational  model  of  folate  metabolism
coupled with the reactions of the methylation cycle. This model would help to
further explore the dynamics of this relationship and could be used to investigate
how disruptions to these processes result in aberrant DNA methylation status,
specifically gene promoter hypermethylation.
Key Points 
 Folate metabolism has a vital role to play in health and possibly intrinsic
ageing
 Folates  supply  methyl  groups  for  DNA methylation reactions  which  are
central to gene regulation. 
 Dynamic computational models have been successfully used to study the
complexities  of  folate  metabolism  and  the  DNA  methylation  cycle
respectively, but no model has fully coupled both systems.  
 To combine both systems computationally it is important to account for
the inherent stochasticity which influences the dynamics of both systems. 
 Incorporating inherent biochemical and molecular variability will  provide
an improved understanding of how perturbations to these systems impact
the onset of disease and will  help to further elucidate the bidirectional
relationship between ageing and DNA methylation.
Glossary
Deterministic model A  model  which  assumes  variability  does  not  impact  the
system of interest. The model will produce the same output
given the same initial conditions and parameters. 
Extrinsic noise Fluctuations in the factors external to the biological system
of  interest  e.g.  biochemical  fluctuations  in  the  folate
pathway and its impact on gene expression. 
Gillespie algorithm An algorithm used to generate stochastic models of reaction 
networks.
Intrinsic noise Noise associated with a biological system of interest e.g. in 
the case of this review, site specific DNA methylation.
Stochastic model A  model  grounded  in  probability  theory  which  is  used  to
represent the variability inherent in biological processes. In
this  review  we  suggest  FOCM is  combined  with  the  DNA
methylation cycle into a single stochastic model, to capture
the inherent variability in body systems.
Figure1. Folate metabolism and its intersection with DNA Methylation: Ingested
folates, are the cofactors for the de novo synthesis of methyl groups. Methyl groups on 5-
methyltetrahydrofolate are used to re-methylate homocysteine (Hcy) to methionine, with
the  aid  of  vitamin  B12  and  methionine  synthase.  This  reaction  regenerates
tetrahydrofolate, the metabolically active form of folate. Methionine is a precursor of S-
adenosylmethionine  (SAM),  which  has  a  predominant  role  to  play  in  the  majority  of
biochemical  methyl  donation  events,  including  that  of  DNA  methylation.  DNA
methyltransferase 1 is central to maintaining genomic methylation patterns, while DNA
methyltransferase 3a and 3b are both involved in  de novo methylation reactions. Ten
eleven translocation (TET) dioxygenases are actively involved in demethylating cytosine,
while CH3 groups are also lost passively. Pink circles indicate methylated CpG’s. 
Figure 2. Stochastic contributions to CpG island methylation: Methylation density
is  affected by intrinsic  and extrinsic  noise.  On the one hand noise is  necessary and
evolution has finely tuned this system so that stochasticity helps to maintain average
methylation  density  in  young  cells.  However,  the  ageing  process  results  in  gradual
increase in stochasticity which eventually culminates with promoter hypermethylation.
During aging gene promoter methylation has been identified within a wide variety of
genes involved in health-span/ageing (Refer to table 4 for full function and description).
Included also are  the  equations which  define intrinsic  and extrinsic  noise,  which are
discussed in the main text (Mathematical equations based on framework introduced by
Elowitz colleagues (2002) [113]).  Part  B presents a summary of  the combined model
represented by a set of indicative reactions which could be modelled using propensity
functions.  Abbreviations:  F,  folate;  THF,  tetrahydrofolate;  5MTHF,  5-
methyltetrahyrofolate; 510MTHF, 5,10 methylenetetrahydrofolate; Met, methionine; SAM,
S-adenosylmethionine;  SAH,  S-adenosylhomocysteine;  Hcy,  homocysteine;  DHF,
dihydrofolate; 10Form, 10,formyl THF.
Tables 1 to 4. 
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Table 1 A summary of the models of folate metabolism cited in the text. 
Authors Title Model Overview/Predictions Computational Methods
Used
Jackson
and
Harrap
(1973)
[64]
Studies  with  a
mathematical
model  of  folate
metabolism
Included  the  main  reactions
involved  in  cellular  folate
metabolism  in  mouse  leukaemia
cells.  Used to  predict  time  course
changes in purine and thymidylate
biosynthesis rates.  
A deterministic framework
consisting  of  a  system of
integrated  equations.
Kinetic  parameters  were
determined  from  pre-
existing  experimental
data.
Nijhout  et
al.  (2004)
[65]
A  mathematical
model  of  the
folate cycle: new
insights  into
folate
homeostasis
Folate  cycle  underpinned  by
enzyme  kinetics.  Used  to  explore
the  ‘methyl  trap  hypothesis’  ,  the
effects  of  methotrexate  and
sensitivities  to  variation  in
enzymatic parameters 
A deterministic ODE based
kinetic  model  constructed
using the assumption that
most  reactions  in  the
folate  cycle  are
bimolecular.  
Reed et al.
(2006)
[66]
A  mathematical
model  gives
insights  into
nutritional  and
genetic  aspects
of  folate-
mediated  one-
carbon
metabolism
Model  of  FOCM.  Predictions
included  the  inverse  association
between  hcy  and  very  low  folate
levels,  DNA  methylation  reaction
rate  is  relatively  insensitive  to
changes in  folate  pool  size,  folate
concentrations  become  very  high,
enzyme  velocities  diminish,
mutations  in MTHFR reduces SAM
Deterministic  ODE  model
created by combining the
model  by   Nijhout  et  al.
(2004)  and  models  of
methionine  metabolism
[67, 68]
Neuhouser
et  al.
(2011)
[69] 
Mathematical
modeling
predicts  the
effect  of  folate
deficiency  and
excess  on
cancer-related
biomarkers
FOCM model used by this group. 
Used  to  predict:  the  effect  of  a
broad  range  of  intracellular  folate
concentrations simulating variation
in  folate  status  on  mechanisms
relevant to carcinogenesis.
Deterministic model based
on [66]. 
Duncan  et
al.  (2013)
[70] 
A  Population
Model  of  Folate-
Mediated  One-
Carbon
Metabolism[70]
Compartmental  body  model  folate
metabolism.
Showed tissue and plasma folate is
highly  correlated,  but  liver  and
plasma  folate  much  less  so.
Oxidative  stress  increases  the
plasma SAM/SAH ratio. 
Models from [65, 66] were
incorporated into liver and
plasma compartment.
Coupled set of ODEs
Random  number  used  to
generate  a  virtual
population  of  10000
individual  each  with
different folate metabolism
Model  constructed  using
Matlab
Salcedo-
Sora and
Mc  Auley
(2016)
[63]
A  mathematical
model  of
microbial folate
biosynthesis and
utilisation:
implications for
antifolate
development
First  model  to  be  assembled  of
folate biosynthesis and utilisation. 
The  model  suggested  a  particular
small  set  of  folate  intermediates
are  specific  targets  which  could
complement  current  antifolates,
and  the  model  substantiates  the
case  for  a  substrate  cycle  in  the
folinic acid biosynthesis reaction.
Deterministic ODE model
Folate  pathway  informed
by the KEGG database 
http://www.genome.jp/keg
g/) and kinetic parameters
were  compile  from  the
enzyme database BRENDA
http://www.brenda-
enzymes.org/  
Table 2 A summary of DNA methylation models cited in the text.
Authors Title Model Features /Predictions Computational Methods 
Used
Capra et 
al. 
(2014) [7
1]
Modeling DNA
methylation 
dynamics with
approaches 
from 
phylogenetics
The model was capable of inferring 
unobserved CpG methylation states 
from observations at the same sites 
in related cell types (90% correct).
Continuous-time Markov chain
approach. 
R source code: 
www.kostkalab.net/software.
Genereux 
et al. 
(2005)
[72]
A population-
epigenetic 
model to infer
site-specific 
methylation 
rates from 
double-
stranded DNA 
methylation 
patterns.
Population-model of DNA 
methylation dynamics. Can infer 
site-specific rates of both 
maintenance and de novo 
methylation values. 
Probabilistic model designed 
to track the frequencies of 
methylated, hemimethylated, 
and unmethylated CpG/CpG 
dyads at a given CpG site 
across a population of cells 
from a single tissue of a single
individual.
Flottmann
et al. 
(2012)
[73] 
A stochastic 
model of 
epigenetic 
dynamics in 
somatic cell 
reprogrammin
g
Describes the interplay between 
gene expression, chromatin 
modifications, and DNA methylation. 
Infers cytosine methylation rates at 
several sites within the promoter of 
the human gene FMR1.
Probabilistic Boolean networks
to represent two kinds of 
stochasticity.
Zheng et 
al. (2013)
[74] 
CpGIMethPred
: 
computational
model for 
predicting 
methylation 
status of CpG 
islands in 
human 
genome
Machine-based models used to 
predict the methylation status of the 
CpG islands in the human genome 
under normal conditions. 
Three part model systems to 
obtain CpG island map. This 
involved database extraction 
of methylation data, feature 
extraction and statistical 
predictive modelling. 
Feinberg 
et al.
(2010)
[75]
Evolution in 
health and 
medicine 
Sackler 
colloquium: 
Stochastic 
epigenetic 
variation as a 
driving force 
of 
development, 
evolutionary 
adaptation, 
and disease
Epigenetic evolutionary model. 
Provided evidence for stochastic 
epigenetic variation, a heritable 
genetic mechanism for variable 
methylation, and genetically 
inherited stochastic variation in 
evolution, in changing environments 
mediated epigenetically. 
Expanded the Fisher-Wright 
neutral selection model.
Przybilla 
et al. 
(2014)
[76]
Understandin
g epigenetic 
changes in 
aging stem 
cells--a 
computational
model 
Used a model to explore age-related 
changes in DNA methylation within 
stem cells and simulations 
suggested homing at stem cell 
niches retarded epigenetic ageing.
Utilised  the model of DNA by 
Sontag et al. (2006) [79] 
approach
Yatabe et 
al. (2001)
[77]
Methylation 
patterns and 
mathematical 
models reveal
dynamics of 
stem cell 
turnover in 
the human 
colon
Experimental work and simulations 
suggest human crypts are long-lived,
accumulate random methylation 
errors, and contain multiple stem 
cells that go through “bottlenecks” 
during life.
Stochastic model. 
Crypts were simulated with a 
methylation error rate of 2 × 
10−5 per CpG site per division,
and one division per day. 
Otto et al.
(1990)
[78]
DNA 
methylation in
eukaryotes: 
kinetics of 
demethylation
and de novo 
methylation 
during the life
cycle. 
Steady state/equilibrium achieved 
such that the proportion  of sites 
which are newly 
methylated equals the proportion 
of sites which become demethylated
in a cell generation. 
Kinetic model that represents 
methylation and 
demethylation.  It 
incorporates values for de 
novo methylation and the 
error rate equation based 
model that ignores 
randomness. 
Sontag et
al. (2006)
[79]
Dynamics, 
stability and 
inheritance of 
somatic DNA 
methylation 
imprints.
Describes the evolution of hypo- to 
hypermethylated equilibria as a 
result of methylation noise in a finite 
system of CpG sites.
Markov-chain model, CpGs 
can change methylation 
states during cell division only
based on probabilities for 
conservation/ 
maintenance/loss and de 
novo methylation.
McGovern
et al. 
(2012)
[80]
A dynamic 
multi-
compartment
al model of 
DNA 
methylation 
with 
demonstrable 
predictive 
value in 
hematological
malignancies.
Was able to fully represent the full 
suite of DNA 
methylation/demethylation reactions
and was used as a tool for predicting
haematological malignancies
Constructed with partial 
differential equations.
Riggs and
Xiong 
(2004)
[82]
Methylation 
and 
epigenetic 
fidelity
Methylation at most sites in cell 
lines, and in tissue cell types is 
stochastically variable to a certain 
extent, with each site depending on 
site-specific probabilities. 
The stochastic methylation 
model assumes that for each 
CpG dyad in each DNA 
molecule there is a certain 
efficiency (probability) of 
methylation maintenance 
failure or de novo 
methylation. 
Jeltsch 
and 
Jurkowska
(2014)
[83]
New concepts 
in DNA 
methylation
Added to the Riggs model [82] by 
including the rate of cell division as 
well as active and passive 
demethylation.
Stochastic equation model 
with rates of cell division and 
rates of active and passive 
demethylation.
Haerter 
et al. 
(2014)
[84]
Collaboration 
between CpG 
sites is 
needed for 
stable somatic
inheritance of 
DNA 
methylation 
Compared the standard/classical 
model to a collaborative model and 
showed that the standard model is 
inconsistent with many experimental
observations. 
Stochastic model 
implemented using the 
Gillespie algorithm [112].
states 
Olariu et 
al. (2016)
[85]
Nanog, Oct4 
and Tet1 
interplay in 
establishing 
pluripotency.
Assembled a regulatory network 
model of Oct4, Nanog and Tet1 
which included positive feedback 
loops involving DNA-demethylation 
around the promoters of Oct4 and 
Tet1. Provides a template for novel 
framework combining transcription 
regulation with DNA methylation 
modifications
To model methylation the 
stochastic model by Haerter 
et al. (2014) [84] was used. 
Table 3. Examples of kinetic parameters available for assembly of a deterministic model
Authors Reaction Parameters 
identified 
Cell line Monoglutama
ted or 
polyglutamat
ed
Study Details
McEntee et 
al. (2011)
[128].
Dihydrofolate-> 
Tetrahydrofolate
Vmax =0.0132 
µm/min/mL
Km=20.1 µM
Human cell line 
cell line BT474.
Polyglutamated
*
The kinetics of the dihydrofolate 
reductase enzyme were compared to
a similar enzyme in order to 
determine its parameters.
Christensen 
et al. (2005)
[129].
Tetrahydrofolate-> 5,10-
Methylenetetrahydrofolate
Vmax 
=22.5µm/min/mL
Km=412 µM
Human homology 
model.
Polyglutamated The kinetics of this reaction were 
determined using a human 
homology model of NAD-dependent 
methylenetetrahydrofolate 
dehydrogenase-cyclohydrolae.
Burda et al. 
(2015) [130]
Smith et al 
(1990) [131].
5,10-
Methylenetetrahydrofolate->5-
methyltetrahydrofolate
Km =29.95 µM
Specific activity 
=0.005µmol/min/
mg
Human skin 
fibroblasts [130] 
and human liver 
cells for specific 
activity [131]
Polyglutamated Mean km value taken from [130]. 
Specific activity taken from analysis 
of human liver [131].
Wolthers and
Scrutton 
(2009) [132].
5-methyltetrahydrofolate+  
Homocysteine ->Methionine 
+Tetrahydrofolate
Km =29.95 µM
Specific activity 
=1.54 
µmol/min/mg
Human MS derived
from Pichia
pastoris.
Polyglutamated The kinetics of human methionine 
synthase were identified by its 
expression and purification from 
Pichia pastoris.
Kotb and 
Kredich 
(1985) [133].
Methionine-> s-adenosyl 
methionine
Km =3.3µM
Specific activity 
=12.2 
µmol/min/mg
Human 
lymphocytes
Polyglutamated Adenosylmethionine synthetase was 
purified from human lymphocytes. 
Bacolla et al 
(2001) [134] 
Pfeife et al. 
(1983) [135].
DNA+s-adenosyl methionine->
s-adenosyl homocysteine + 
CpGCH3 
(maintenance reaction)
KmAldomet =11µM
KmDNA =23µM
Specific activity 
=0.000016 
µmol/min/mg
Human 
constructs[134]
And human 
placenta 
[135].
Polyglutamated Steady-state kinetic analyses of 
human DNMT1 [134] 
Isolation and characterization of DNA
cytosine 5-methyltransferase from 
human placenta [135].
Roy and 
Weissbach 
(1975) [136].
CpGCH3-> CpG (de novo 
reaction)
KmAldomet 
=0.00325µM
KmDNA =0.086µM
Specific activity 
= 0.000013 
µmol/min/mg
HeLa cells Polyglutamated Enzymes were purified from HeLa 
cell nuclei by chromatography on 
diethylaminoethyl cellulose.
CpG-> CpGCH3 (Active 
Demethylation)
Unidentified 
*Although the studies do not state explicitly the chemical form of the folates, as they were cell line assays it can be assumed 
the chemical administered to the cells was monoglutamated. However, it is likely to have become polyglutamated by the time 
the enzymatic assay took place. 
Table 4. Examples of Genes associated ageing/health-span which have been found to be
hypermethylated with age
Gene Full name Function Study and Conclusions* Source
BRAC1 Breast 
cancer 1
DNA repair Cancer study: Both controls 
and cancer patients displayed
methylation of BRAC1  
Bosviel et al. (2012) 
[137]
IGF2 Insulin like 
growth 
factor II
Promotes cell 
growth and division.
Cancer study: methylation 
change in IGF2 promoter 
during aging and 
carcinogenesis.
Issa et al. (1996) [24]
GSTM1 Glutathione
S-
transferase
isoform 
mu1 
(GSTM1)
Codes for an 
enzyme that has a 
role to play in the 
prevention of 
oxidative damage 
GSTM1 promoter methylation
was confirmed by CpG island 
methylation in age related 
macular degeneration 
subjects. 
Hunter et al. (2012) 
[138]
GSTP1 Glutathione
S-
transferase
P
Codes for an 
enzyme that has an
important role to 
play in the 
prevention of 
oxidative damage.
Cancer study: Changes in 
Normal Human Prostate 
Tissues.
Increase in promoter 
methylation with age for CpG 
islands in normal prostate 
tissue samples in several 
genes.
Kwabi-Addo et al. 
(2007) [139]
MLH1 MutL 
homolog 1
Codes for a protein 
involved in DNA 
mismatch repair
Cancer study: found partially 
methylated alleles in 44% of 
patients <60yrs and in 83% 
≥ 80 yrs. Fully methylated 
alleles in 55% of patients with
Microsatellite instability + 
tumours. 
Nakagawa et al. 
(2001) [140]
Cancer study: found 
hypermethylation in the 
normal colonic mucosa of 
patients with colorectal 
cancer. Methylation of CpG 
islands is seen in the normal 
colonic mucosa and increased
with age. 
Kawakami et al. 
(2006) [141]
SOD2 Codes for an 
enzyme that helps 
prevent oxidative 
damage 
Osteoarthritis (OA) study: 
used human and guinea pig 
tissue samples. SOD2 
promoter had significant DNA
methylation alterations in OA 
cartilage. 
Scott et al. (2010) 
[142]
WRN Werner 
syndrome
Codes for a DNA 
helicase that 
participates in 
genome 
maintenance
Immunosenescence study: 
Analysis of the 361 bp WRN 
promoter CpG island showed 
a slight increase in 
methylation with age of its 
methylation status. Authors 
report that it was biologically 
negligible. 
Polosak et al. (2011) 
[143]
ER Estrogen 
receptor 
Estrogen receptor Cancer study: CpG island 
methylation, of ER gene in a 
subpopulation of cells 
increased as a direct function
of age in human colonic 
mucosa.
Issa et al. (1994)[27]
DR3 The death 
receptor 3 
(DR3) gene
Member of the 
apoptosis-inducing 
fas receptor gene 
family
Rheumatoid Arthritis (RA) 
study: Hypermethylated 
promoter region of DR3, the 
death receptor 3 gene, in 
rheumatoid arthritis synovial 
cells.
Takami et al. (2006)
[144]
(OP-1, 
BMP-7)
Oestrogeni
c protein 1
Bone maintenance Osteoporosis study: 
Methylation of the OP-1 
promoter was found in 
chondrocytes from tissue 
obtained from older adults 
(study age range 19-86yrs). 
Loeser et al. (2009)
[145]
